← United States · Coverage record
US · SEC FORM 4
Applied Therapeutics, Inc.
APLT · — · CIK 0001697532 · Healthcare
INSIDER SIGNAL
0 qualifying P purchase groups
in the current 180-day scoring window
0 Form 4 transaction lines observed in the same window
0 sales · 0 option, withholding, award, gift or other lines
WHY NO ACTIVE SIGNAL?
Score anatomy
No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.
Why is there no score?
- No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
- Sales and other Form 4 activity remain visible as context and do not create a negative score.
Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.
Insider activity timeline
No Form 4 transaction event is present in the current 180-day window.
Purchase breadth, concentration & cluster buying
These modules activate when qualifying purchases enter the 180-day research window.
SIGNAL HISTORY
Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2023-12-01 · Kanter Stacy J..
Recent Form 4 activity
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
Market context
Market context capture is under review for APLT. Last attempt: 2026-10-18T21:13:32.804706+00:00. —
Short interest
The FINRA report lists no short interest for this ticker.
FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.
Historical equity purchases
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2023-12-01 | Kanter Stacy J. | Purchase (P) | Common Stock | 30,000 | USD 2.18 | USD 65,400 | SEC filing ↗ |
| 2022-10-14 | Shendelman Shoshana | Purchase (P) | Common Stock | 50,000 | USD 0.65 | USD 32,500 | SEC filing ↗ |
| 2022-10-13 | Shendelman Shoshana | Purchase (P) | Common Stock | 73,256 | USD 0.56 | USD 41,023 | SEC filing ↗ |
| 2022-10-12 | Shendelman Shoshana | Purchase (P) | Common Stock | 38,153 | USD 0.52 | USD 19,840 | SEC filing ↗ |
| 2022-06-27 | ALEXANDRIA REAL ESTATE EQUITIES, INC.; Alexandria Equities No. 7, LLC; Alexandria Venture Investments, LLC | Purchase (P) | Common Stock | 3,500,000 | USD 1.00 | USD 3,500,000 | SEC filing ↗ |
| 2022-03-23 | Perfetti Riccardo | Purchase (P) | Common Stock | 30,000 | USD 1.97 | USD 59,100 | SEC filing ↗ |
| 2022-03-22 | Perfetti Riccardo | Purchase (P) | Common Stock | 21,961 | USD 1.98 | USD 43,483 | SEC filing ↗ |
| 2022-03-21 | Perfetti Riccardo | Purchase (P) | Common Stock | 12,548 | USD 1.85 | USD 23,214 | SEC filing ↗ |
| 2021-09-14 | Shendelman Shoshana | Purchase (P) | Common Stock | 9,300 | USD 14.49 | USD 134,757 | SEC filing ↗ |
| 2021-09-13 | Shendelman Shoshana | Purchase (P) | Common Stock | 701 | USD 14.69 | USD 10,298 | SEC filing ↗ |
| 2021-02-19 | Kanter Stacy J. | Purchase (P) | Common Stock | 6,500 | USD 22.86 | USD 148,590 | SEC filing ↗ |
| 2021-02-17 | ALEXANDRIA REAL ESTATE EQUITIES, INC.; Alexandria Equities No. 7, LLC; Alexandria Venture Investments, LLC | Purchase (P) | Common Stock | 43,478 | USD 23.00 | USD 999,994 | SEC filing ↗ |
| 2020-01-28 | MARCUS JOEL S | Purchase (P) | Common Stock | 500 | USD 45.50 | USD 22,750 | SEC filing ↗ |
| 2020-01-28 | Kanter Stacy J. | Purchase (P) | Common Stock | 6,500 | USD 45.50 | USD 295,750 | SEC filing ↗ |
Form 4 evidence
20 transaction lines in the latest 365-day window; 335 in local history.
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-02-03 | Kanter Stacy J. | U (U) | Common Stock | 42,500 | USD — | USD — | SEC filing ↗ |
| 2026-02-03 | Kanter Stacy J. | D (D) | Common Stock | 22,500 | USD — | USD — | SEC filing ↗ |
| 2026-02-03 | SKYLER JAY S | U (U) | Common Stock | 42,500 | USD — | USD — | SEC filing ↗ |
Show recent Form 4 evidence (20 grouped rows)
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-02-03 | Kanter Stacy J. | U (U) | Common Stock | 42,500 | USD — | USD — | SEC filing ↗ |
| 2026-02-03 | Kanter Stacy J. | D (D) | Common Stock | 22,500 | USD — | USD — | SEC filing ↗ |
| 2026-02-03 | SKYLER JAY S | U (U) | Common Stock | 42,500 | USD — | USD — | SEC filing ↗ |
| 2026-02-03 | SKYLER JAY S | D (D) | Common Stock | 22,500 | USD — | USD — | SEC filing ↗ |
| 2026-02-03 | Lerner Teena | U (U) | Common Stock | 82,922 | USD — | USD — | SEC filing ↗ |
| 2026-02-03 | Lerner Teena | D (D) | Common Stock | 22,500 | USD — | USD — | SEC filing ↗ |
| 2026-02-03 | Hooks Corwin Dale | U (U) | Common Stock | 5,753 | USD — | USD — | SEC filing ↗ |
| 2026-02-03 | Hooks Corwin Dale | D (D) | Common Stock | 862,500 | USD — | USD — | SEC filing ↗ |
| 2026-02-03 | Funtleyder Leslie D. | U (U) | Common Stock | 152,959 | USD — | USD — | SEC filing ↗ |
| 2026-02-03 | Funtleyder Leslie D. | D (D) | Common Stock | 2,375,000 | USD — | USD — | SEC filing ↗ |
| 2026-02-03 | Chinoporos Constantine | U (U) | Common Stock | 57,111 | USD — | USD — | SEC filing ↗ |
| 2026-02-03 | Chinoporos Constantine | D (D) | Common Stock | 1,000,000 | USD — | USD — | SEC filing ↗ |
| 2026-02-03 | Bailey Evan Prescott | U (U) | Common Stock | 60,901 | USD — | USD — | SEC filing ↗ |
| 2026-02-03 | Bailey Evan Prescott | D (D) | Common Stock | 1,235,915 | USD — | USD — | SEC filing ↗ |
| 2026-01-01 | Funtleyder Leslie D. | Award / grant (A) | Common Stock | 150,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2025-12-19 | Hooks Corwin Dale | Award / grant (A) | Common Stock | 312,500 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2025-12-19 | Funtleyder Leslie D. | Award / grant (A) | Common Stock | 1,187,500 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2025-12-19 | Chinoporos Constantine | Award / grant (A) | Common Stock | 437,500 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2025-12-19 | Bailey Evan Prescott | Award / grant (A) | Common Stock | 437,500 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2025-12-16 | Kanter Stacy J. | Sale (S) | Common Stock | 43,000 | USD 0.11 | USD 4,730 | SEC filing ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
Snapshot & identity
| Snapshot date | 2026-10-18 |
|---|---|
| Ranking version | US-v1.2 |
| Data quality | PASS ELIGIBLE · — |
| Ticker | APLT |
| CIK | 0001697532 |
| Sector | Healthcare |
| Industry | — Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| Exchange | — |
Data coverage
| Local Form 4 history | 335 transaction lines from 2020-01-28 to 2026-02-03 15 P purchase lines · 164 S sale lines · 156 other lines |
|---|---|
| SEC company submissions | Open SEC filings ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.